Cetus
Executive Summary
Will be granted an exclusive royalty-bearing patent license by the National Technical Information Service, Department of Commerce, to practice an invention embodied in U.S. patent "Activated Killer Monocytes: Tumoricidal Activity and Method of Monitoring Same." The objectives of the invention are to produce "a substantially pure, clinical grade, activated killer monocyte that will more effectively kill cancer cells, to assay AKM effectiveness in vitro, and to facilitate the body's immune response, Dec. 7 Federal Register notice announcing the license says....